Skip to main content
SearchLoginLogin or Signup

Reviews of "Estimating The Uncertain Effect of the COVID Pandemic on Drug Overdoses"

Reviewer: H Palis (The University of British Columbia) | 📒📒📒 ◻️◻️, A Denham (Harvard Medical School) | 📒📒📒 ◻️◻️ Anonymous | 📕 ◻️◻️◻️◻️

Published onApr 06, 2023
Reviews of "Estimating The Uncertain Effect of the COVID Pandemic on Drug Overdoses"
key-enterThis Pub is a Review of
Estimating The Uncertain Effect of the COVID Pandemic on Drug Overdoses
Description

ABSTRACTObjectiveU.S. drug-related overdose deaths and Emergency Department (ED) visits rose in 2020 and again in 2021. Multiple studies and the news media attributed this rise primarily to increased drug use resulting from the societal disruptions related to the coronavirus (COVID-19) pandemic. A competing explanation is that higher overdose deaths and ED visits may instead have been a continuation of pre-pandemic trends in synthetic-opioid deaths. We assess the evidence on whether increases in overdose deaths and ED visits are likely to be causally related to the COVID-19 pandemic, increased synthetic-opioid use, or some of both.MethodsWe use national data from the Centers for Disease Control and Prevention (CDC) on rolling 12-month drug-related deaths (2015-2021); CDC data on monthly ED visits (2019-September 2020); and ED visit data across 21states from a national ED group (January 2016-June 2022). We study drug overdose deaths per 100,000 persons during the pandemic period, and ED visits for drug overdoses, compared to predicted levels based on pre-pandemic trends.ResultsMortalityNational overdose mortality increased from 21/100,000 in 2019 to 26/100,000 in 2020 and 30/100,000 in 2021. The 2020 increase is well-predicted by models that extrapolate pre-pandemic trends for rolling 12-month mortality to the pandemic period, consistent with higher mortality reflecting continuation of those trends. Placebo analyses (which assume the pandemic started earlier or later than March 2020) do not provide evidence for a change in trend in or soon after March 2020. State-level analyses of actual-minus-predicted mortality, relative to pre-pandemic trends, show no consistent pattern. The state-level results support state heterogeneity in overdose mortality trends, and do not support the pandemic being a major driver of overdose mortality.ED visitsED overdose visits rose during our sample period, reflecting a worsening opioid epidemic, but rose at similar rates during the pre-pandemic and pandemic periods.ConclusionThe causes of rising overdose mortality in 2020 and 2021 cannot be definitely determined, but the observed increases can be largely explained by a continuation of pre-pandemic trends in synthetic-opioid deaths, principally fentanyl. In contrast to prior studies, we do not find support for the pandemic having been a principal driver of rising mortality. Policymakers need to directly address the synthetic opioid epidemic, and not expect a respite as the pandemic recedes.

To read the original manuscript, click the link above.

Summary: This preprint aims to use a counterfactual based approach to estimate the COVID-19 pandemic’s impact on drug overdose rates in the United States. Overall, while the reviewers agree that this is an important topic to explore, there are a range of concerns about the methodological approach used to create the model.

Reviewer 1 (Heather P…) | 📒📒📒 ◻️◻️

Reviewer 2 (Alina D…) | 📒📒📒 ◻️◻️

Reviewer 3 (Anonymous) | 📕 ◻️◻️◻️◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below. 

Comments
2
?
Suleman Smith:

Hi,
It is really help post for all communities.
Also Check: Largest Crocodiles

?
will james:

It’s perfect for people who don’t have a lot of space for cardio machines, and it’s also a great way to improve coordination and agility. Look for a jump rope that’s adjustable in length, so you can customize it to your height. Visit this blog